Mesenchymal Chondrosarcoma: A Small Cell Neoplasm with Polyphenotypic Differentiation.

Area of Science:

• Oncology
• Pathology
• Molecular Biology

Background:

• Mesenchymal chondrosarcoma is a rare bone and soft tissue tumor.
• Its differentiation potential is not fully understood.
• Understanding its immunophenotype aids in differential diagnosis.

Purpose of the Study:

• To investigate the clinicoradiographic, microscopic, and immunophenotypic features of mesenchymal chondrosarcoma.
• To explore the potential for polyphenotypic differentiation in these tumors.
• To clarify the expression of various markers in mesenchymal chondrosarcoma.

Main Methods:

• Analysis of 21 mesenchymal chondrosarcoma tumors (11 primary, 10 metastatic).
• Immunophenotypic profiling using antibodies against MIC2, S-100, desmin, myoD1, myogenin, myoglobin, smooth-muscle actin, cytokeratin, neuron-specific enolase, and HMB-45.
• Correlation of immunophenotypic findings with clinicoradiographic and microscopic features.

Main Results:

• MIC2 gene protein (p30/32(MIC2)) expressed in small cells of 17 tumors.
• S-100 protein positive in cartilaginous areas of 20 tumors.
• Focal desmin positivity in 8 cases; diffuse desmin with focal myoD1 in 2 primary tumors, suggesting rhabdomyoblastic differentiation.
• Neuron-specific enolase showed focal positivity in 11 tumors.
• All tumors negative for myogenin, myoglobin, cytokeratins, and HMB-45.

Conclusions:

• Mesenchymal chondrosarcoma demonstrates polyphenotypic differentiation beyond cartilaginous features.
• Focal and, rarely, diffuse rhabdomyoblastic differentiation can occur in the small cell component.
• Immunophenotypic findings highlight overlaps with other small cell malignancies, aiding diagnosis.